Opko Health Inc (NASDAQ:OPK)’s traded shares stood at 1.23 million during the latest session, with the company’s beta value hitting 1.63. At the last check today, the stock’s price was $1.60, to imply a decrease of -0.25% or $0.0 in intraday trading. The OPK share’s 52-week high remains $1.75, putting it -9.37% down since that peak but still an impressive 46.88% since price per share fell to its 52-week low of $0.85. The company has a valuation of $1.09B, with an average of 4.09 million shares in intraday trading volume over the past 10 days and average of 3.32 million shares over the past 3 months.

Analysts have given a consensus recommendation of Hold for Opko Health Inc (OPK), translating to a mean rating of 1.00. Of 6 analyst(s) looking at the stock, 0 analyst(s) give OPK a Sell rating. 0 of those analysts rate the stock as Overweight while 4 advise Hold as 2 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at -0.08.

Opko Health Inc (NASDAQ:OPK) trade information

After registering a -0.25% downside in the latest session, Opko Health Inc (OPK) has traded red over the past five days. The 5-day price performance for the stock is 10.07%, and 7.11% over 30 days. With these gigs, the year-to-date price performance is 5.70%. Short interest in Opko Health Inc (NASDAQ:OPK) saw shorts transact 95.86 million shares and set a 33.99 days time to cover.

The extremes give us $3 and $4 for target low and target high price respectively. As such, OPK has been trading -150.0% off suggested target high and -87.5% from its likely low.

Opko Health Inc (OPK) estimates and forecasts

Looking at statistics comparing Opko Health Inc share performance against respective industry, we note that the company has underperformed competitors. Opko Health Inc (OPK) shares are 22.77% up over the last 6 months, with its year-to-date growth rate lower than industry average at -4.00% against 15.90%. Revenue is forecast to grow 12.97% this quarter before jumping 33.33% for the next one. The rating firms project that company’s revenue will shrink -20.70% compared to the previous financial year.

Revenue forecast for the current quarter as set by 5 analysts is 155.24M. Meanwhile, for the current quarter, a total of 3 analyst(s) estimate revenue growth to 153.73M.Earnings reports from the last fiscal year show that sales brought in 181.9M and 173.69M respectively in the corresponding quarters. In this case, analysts estimate current quarter sales to fall -14.66% before dropping -11.49% in the following quarter.

An assessment of the company’s 5-year growth patterns shows that annual earnings grew an estimated 1.56% for the past 5-year period. While 2024 is set for a 12.00% return in earnings, projections for the next 5 years are at 12.00% annually.

OPK Dividends

Opko Health Inc has its next earnings report out on 2025-Feb-25. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.

Opko Health Inc (NASDAQ:OPK)’s Major holders

Opko Health Inc insiders hold 54.40% of total outstanding shares, with institutional holders owning 28.31% of the shares at 62.08% float percentage. In total, 28.31% institutions holds shares in the company, led by RUBRIC CAPITAL MANAGEMENT LP. As of 2024-06-30, the company held over 44.42 million shares (or 6.2843% of shares), all amounting to roughly $55.53 million.

The next major institution holding the largest number of shares is BLACKROCK INC. with 29.25 million shares, or about 4.1373% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $36.56 million.